structures exhibiting a wide range of pharmaceutical
activities.9 In addition to the hydroxyl and amine function-
ality, the azide is also a very common functional group and
serves as both an encoded amine10 and triazole precursor.
Triazoles have become targets in the fields of medicinal
chemistry11 and synthetic organic chemistry12 after the
revolutionary discovery of a new triazole synthesis.13 The
toxicity of the residual copper catalyst in biological studies
makes the metal-free triazole protocols more attractive in
drug discovery programs.14 Despite all of these beneficial
features of azides, thechemicalorphotooxidationofazides
bearingalkyl furansisexceedinglyrare.15 The only account
noted thus far was photooxidation of 2-(3-azidoalkyl)
furan carried out in order to establish the substituted
piperidine ring system.
Scheme 1. Photooxygenation of 1-Azido- and 2-Azidoalkylfurans
Here, we report herein the discovery of both a new
triazole formation method and endoperoxide rearrange-
ment pathway with two concomitant CꢀC bond cleavages
in the photooxydation of azidoalkyl furans. These trans-
formations were discovered during our research program,
which is primarily focused on the furan-based synthesis of
diverse structural motifs. Syntheses of azidoalkyl furans
were successively achieved by employing and tuning ap-
propriate bond formation and functional group trans-
formation methodologies. First, we studied the photo-
oxygenation of 2-(1-azidopentyl)furan (1) at ꢀ78 °C
(Scheme 1). A solution of 1 and a catalytic amount of
TPP (meso-tetraphenylporphyrin) were dissolved in DCM,
cooled toꢀ78°C, and then irradiated with a 500 W halogen
lamp while oxygen was bubbled into the solution. Upon
completion of the reaction (as monitored by TLC), excess
Me2S was added into the reaction mixture and then the
resulting mixture was allowed to warm to rt to completely
cleave the unstable peroxide bond. After the removal of
(8) (a) Tofi, M.; Koltsida, K.; Vassilikogiannakis, G. Org. Lett. 2009,
11, 313. (b) Pavlakos, E.; Georgiou, T.; Tofi, M.; Montagnon, T.;
Vassilikogiannakis, G. Org. Lett. 2009, 11, 4556. (c) Montagnon, T.;
Tofi, M.; Vassilikogiannakis, G. Acc. Chem. Res. 2008, 41, 1001. (d)
Zhu, L. Z.; Talukdar, A.; Zhang, G. S.; Kedenburg, J. P.; Wang, P. G.
Synlett 2005, 1547. (e) Teijeira, M.; Suarez, P. L.; Gomez, G.; Teran, C.;
Fall, Y. Tetrahedron Lett. 2005, 46, 5889. (f) Burke, M. D.; Berger,
E. M.; Schreiber, S. L. J. Am. Chem. Soc. 2004, 126, 14095. (g) Harris,
J. M.; Keranen, M. D.; Nguyen, H.; Young, V. G.; O’Doherty, G. A.
Carbohydr. Res. 2000, 328, 17. (h) Abrams, J. N.; Babu, R. S.; Guo, H.;
Le, D.; Le, J.; Osbourn, J. M.; O’Doherty, G. A. J. Org. Chem. 2008, 73,
1935.
(9) (a) Leverett, C. A.; Cassidy, M. P.; Padwa, A. J. Org. Chem. 2006,
71, 8591. (b) Cassidy, M. P.; Padwa, A. Org. Lett. 2004, 6, 4029.
(c) Haukaas, M. H.; O’Doherty, G. A. Org. Lett. 2001, 3, 401.
(10) Brase, S.; Gil, C.; Knepper, K.; Zimmermann, V. Angew. Chem.,
Int. Ed. 2005, 44, 5188.
1
solvent, H NMR showed that the starting material (1)
had been consumed and converted to the E/Z mixtures of
aldehyde 3 which was found to be unstable at 0 °C. The
crude product was sufficiently clean for structural assess-
1
ment by H and 13C NMR. Interestingly, photooxygena-
(11) (a) Weide, T.; Saldanha, S. A.; Minond, D.; Spicer, T. P.;
Fotsing, J. R.; Spaargaren, M.; Frere, J. M.; Bebrone, C.; Sharpless,
K. B.; Hodder, P. S.; Fokin, V. V. ACS Med. Chem. Lett. 2010, 1, 150.
(b) Kee, J. M.; Villani, B.; Carpenter, L. R.; Muir, T. W. J. Am. Chem.
Soc. 2010, 132, 14327. (c) Diaz, L.; Bujons, J.; Casas, J.; Llebaria, A.;
Delgado, A. J. Med. Chem. 2010, 53, 5248. (d) Minond, D.; Saldanha,
S. A.; Subramaniam, P.; Spaargaren, M.; Spicer, T.; Fotsing, J. R.;
Weide, T.; Fokin, V. V.; Sharpless, K. B.; Galleni, M.; Bebrone, C.;
Lassaux, P.; Hodder, P. Bioorg. Med. Chem. 2009, 17, 5027. (e) Hirose,
T.; Sunazuka, T.; Sugawara, A.; Endo, A.; Iguchi, K.; Yamamoto, T.;
Ui, H.; Shiomi, K.; Watanabe, T.; Sharpless, K. B.; Omura, S.
J. Antibiot. 2009, 62, 277. (f) Whiting, M.; Tripp, J. C.; Lin, Y. C.;
Lindstrom, W.; Olson, A. J.; Elder, J. H.; Sharpless, K. B.; Fokin, V. V.
J. Med. Chem. 2006, 49, 7697.
(12) (a) Kwok, S. W.; Fotsing, J. R.; Fraser, R. J.; Rodionov, V. O.;
Fokin, V. V. Org. Lett. 2010, 12, 4217. (b) Kalisiak, J.; Sharpless, K. B.;
Fokin, V. V. Org. Lett. 2008, 10, 3171. (c) Boren, B. C.; Narayan, S.;
Rasmussen, L. K.; Zhang, L.; Zhao, H. T.; Lin, Z. Y.; Jia, G. C.; Fokin,
V. V. J. Am. Chem. Soc. 2008, 130, 8923. (d) Yoo, E. J.; Ahlquist, M.;
Kim, S. H.; Bae, I.; Fokin, V. V.; Sharpless, K. B.; Chang, S. Angew.
Chem., Int. Ed. 2007, 46, 1730.
tion of the methylfuran analogue of 1 did not show any sign
of the product or starting material. Next, the photo-
oxygenation of 4, with an azide at C-2 of the alkyl chain,
was explored under the developed conditions (Scheme 1).
1
The crude H NMR showed only trace amounts of the
oxidation product 5. Unfortunately, we were unable to
fully characterize 5 due to its instability at rt. The RB
(Rose bengal)-sensitized oxygenations of 1 and 4 in MeOH
were also performed. Sadly, these experiments did not
provide 3 and 5 or any MeO group incorporated product
which is generally observed under these conditions.15 After
these disappointing observations, we turned our attention
to 3-azidoalkyl furan. First, 6 was exposed to the TPP-
1
sensitized oxygenation (Scheme 2). H and 13C NMR
from the isolated product showed new distinctive signals
that appeared at 11.09 (br s), 7.72 (s), 7.65 (s) ppm and
174.5 ppm. Surprisingly, the characteristic aldehyde and
R,β-unsaturated system signals of the expected oxidation
product were not seen in 1H and 13C NMR. In addition, the
expected total carbon signals were one carbon less than
the number of carbons in the starting material. From these
data, it was obvious that we had encountered a new
structural motif in furan oxidation. After this intriguing
(13) Rostovtsev, V. V.; Green, L. G.; Fokin, V. V.; Sharpless, K. B.
Angew. Chem., Int. Ed. 2002, 41, 2596.
(14) (a) Niu, T. F.; Gu, L.; Yi, W. B.; Cai, C. ACS Comb. Sci. 2012,
14, 309. (b) Bernardin, A.; Cazet, A.; Guyon, L.; Delannoy, P.; Vinet, F.;
Bonnaffe, D.; Texier, I. Bioconjugate Chem. 2010, 21, 583. (c) Jewett,
J. C.; Bertozzi, C. R. Chem. Soc. Rev. 2010, 39, 1272. (d) Neef, A. B.;
Schultz, C. Angew. Chem., Int. Ed. 2009, 48, 1498. (e) van Dijk, M.;
Rijkers, D. T. S.; Liskamp, R. M. J.; van Nostrum, C. F.; Hennink,
W. E. Bioconjugate Chem 2009, 20, 2001.
(15) Garcia, I.; Perez, M.; Gandara, Z.; Gomez, G.; Fall, Y. Tetra-
hedron Lett. 2008, 49, 3609.
B
Org. Lett., Vol. XX, No. XX, XXXX